Forte Biosciences, Inc. (FBRX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Forte Biosciences, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -57.85x | -1.87x | -0.82x | -1.25x | -1.38x | -5.76x |
| P/B Ratio | 65.81x | 1.26x | 0.73x | 0.45x | 0.72x | 4.54x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 3.88x | 6.76x | 10.45x | 13.06x | 24.19x | 26.52x |
| Quick Ratio | 3.88x | 6.76x | 10.45x | 13.06x | 24.19x | 26.52x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..